Article Details
Retrieved on: 2021-03-01 06:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotechnology company reported $0.52 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.31 by $0.21. Repligen had a ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here